1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Reading Disability: new trials by email Literature Review of Reading Disability trials Research Report on Reading Disability
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interventions for Reading Disabilities in NF1 Lovastatin, reading tutoring intervention, Placebo Oral Tablet - Neurofibromatosis Type 1, Learning Disability | Phase 2 | Active not recruiting | Vanderbilt University | 120 | 2016-11-01 | 2026-07-01 |
Dyslexia (1) · Learning Disabilities (1) · Neurofibromatosis 1 (1)
Communication Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Language Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Nerve Tissue (1) · Neoplastic Syndromes, Hereditary (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocutaneous Syndromes (1) · Neurodegenerative Diseases (1)
Lovastatin (1)
United States (1)
Laurie Cutting, PhD (1) · Sheryl L. Rimrodt-Frierson, MD (1)
R01HD089474 (1)